Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
9,064,738
-
Shares change
-
-1,688,458
-
Total reported value, excl. options
-
$12,238,611
-
Value change
-
-$2,403,427
-
Number of buys
-
4
-
Number of sells
-
-11
-
Price
-
$1.35
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q1 2016
28 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q1 2016.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,064,738 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (1,700,000 shares), Abingworth LLP (1,600,000 shares), Versant Venture Management, LLC (1,048,601 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (958,920 shares), Point72 Asset Management, L.P. (843,800 shares), Lombard Odier Asset Management (USA) Corp (709,440 shares), Omega Fund Management, LLC (606,100 shares), VANGUARD GROUP INC (549,353 shares), J. Goldman & Co LP (239,260 shares), and ALLIANCEBERNSTEIN L.P. (234,974 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.